MedPath

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

Phase 3
Conditions
skin ulcer
Registration Number
JPRN-jRCT2031210266
Lead Sponsor
Ichioka Shigeru
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps)

Exclusion Criteria

Presence of untreated ulcer infection (redness, swelling, pus, foul odor, fever)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The days to simple surgical intervention (ncluding suturing, grafts or flaps)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath